Craneware plc, the market leader in automated Value Cycle solutions for the US healthcare market, has announced the extension of its share buyback program for a further three months until January 17, 2024. The program will continue under the same terms as previously announced. Craneware's Trisus data and applications platform is chosen by US healthcare providers to plan, execute, and monitor operational and financial performance. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. The company's Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services."